Sumanta Mondal

Dr. Sumanta Mondal


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Closed access
PDF file
VHV. A. N. V. Harita
V. A. N. V. Harita
KDKoustav Dutta
Koustav Dutta
ABAishik Banerjee
Aishik Banerjee
SMSumanta Mondal
Sumanta Mondal

13 December 2024 in Current Indian Science
Verified
Journal Article
Open access
PDF file
SMSumanta Mondal
Sumanta Mondal
SNSourav Nag
Sourav Nag
RPReshmi Paul
Reshmi Paul
NPNaresh Panigrahi
Naresh Panigrahi
PRPartha Roy
Partha Roy
SSSoumitra Sahana
Soumitra Sahana
A broad name for plant compounds with various structures and functions is “phytochemical.” When ingested by humans, phytochemicals may have biological activity. Plant foods, such as fruits, vegetables, whole grains, nuts, and seeds are the most prevalent sources of phytochemicals. Boerhaavia diffusa L. nom. cons. is a perennial creeping herb that grows throughout India. In the Indian medical system, it is generally referred to as “Punarnava”. In some areas of India, it is frequently used to treat jaundice. According to Ayurveda, B. diffusa is categorized as a “Rasayana” herb, which is believed to have anti-aging, disease-prevention, and life-strengthening properties. These properties are thought to significantly impact the global disease burden and the cost and accessibility of healthcare. This one is one of the first Eastern remedies that Ayurveda mentions as a possible treatment for several illnesses. Numerous ethnopharmacological reports highlight its involvement in reproductive, gastrointestinal, respiratory, urinary, hepatic/jaundice, cardiovascular, and cancer problems. Beyond that, because of the plant's therapeutic value derived from flavonoids and polyphenols, physicians and scientists should take more significant advantage of this plant to learn more about its biological and therapeutic qualities. Its taxonomy and geographic description, ethnobotanical insights, and various pharmacological characteristics were the main topics of this paper.

1 July 2025 in Journal of Pharmacy and Bioallied Sciences
Verified
Journal Article
Open access
BBBysani S. Babu
Bysani S. Babu
KDKoustav Dutta
Koustav Dutta
SMSumanta Mondal
Sumanta Mondal
Background: Hypoxia-inducible factor-2alpha (HIF-2α) is a protein, the selective inhibitor of which (belzutifan) is used in the treatment of cancers related to von Hippel-Lindau (VHL) disease. No analytical procedure has been so far reported in the identification of forced degradation products of belzutifan. Thus, the current project was conducted to design and approve the liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) technique to perform a full analysis of it. Objective: This research was to develop and confirm a strong high-performance liquid chromatography (HPLC) procedure in the quantification of belzutifan in the tablet dosage form and to utilize LC-MS/MS in the characterization of the forced degradation products of belzutifan. Approach: The separation was done by the chromatographic method utilizing a Zorbax C 18 column with the mobile phase comprised of acetonitrile and 0.1% formic acid (50:50, v/v), and the flow rate was 1.0 mL/min with 247nm as a detector wavelength. Belzutifan had a retention time of 2.338 min and a total reaction time of 4 min. Results: The derived technique showed great linearity (R2 > 0.999) in the range of concentrations (10-60 μg/ml) and good accuracy, precision, and strength. The forced degradation analysis identified specific degradation products, which were further identified using the LC-MS/MS, thus gathering significant information about the stability profile of belzutifan in stressful environments. Conclusion: This study developed and validated a simple, rapid, cost-effective, and highly sensitive RP-HPLC method for quantitative estimation of belzutifan in tablets. The method complied with ICH guidelines, demonstrating excellent linearity, accuracy, specificity, robustness, and stability. Linearity was achieved over a wide range, with no interference from excipients, confirming its reliability. Relative standard deviations (RSD) were below 2%, indicating precision and reproducibility. Owing to its simplicity and efficiency, the method is suitable for routine quality control in pharmaceutical laboratories.

25 June 2025 in Pharmacognosy Research
Verified
Journal Article
Open access
PDF file
ABAishik Banerjee
Aishik Banerjee
AGArup Ghosh
Arup Ghosh
ANAmartya Nandi
Amartya Nandi
DSDeyasini Saha
Deyasini Saha
SSSantosh Kumar Sahoo
Santosh Kumar Sahoo
SMSumanta Mondal
Sumanta Mondal
Aflatoxin, a mycotoxin origin from food-borne microbes, poses a significant and remarkable risk to the safety and integrity of food. Mycotoxin-producing fungi can infect goods intended for human and animal consumption, impacting both populations. Among mycotoxins, aflatoxin B 1 harms many living organisms, including microorganisms, plants, laboratories, pet animals, and cultured cells. Aflatoxins are incredibly liposoluble and easily absorbed from the exposure site, typically entering the bloodstream through the respiratory and gastrointestinal systems. In humans and animals, the reactive form of aflatoxin, AFB 1 , is metabolized through cytochrome P450 microsomal enzymes into aflatoxins-8,9-epoxide, which then binds with DNA and albumins present in blood serum, forming an active-adducts that damage DNA. Aflatoxins are the well-researched class of mycotoxins, with clear correlations to carcinogenic, hepatotoxic, mutagenic, and teratogenic effects. Therefore, aflatoxin detection is crucial for maintaining food safety and public health, as mycotoxins can withstand high temperatures during storage and cooking. Several analytical and chemical methods can detect, identify, and control aflatoxin contamination with precision, contributing to food safety and public health. Further worldwide research is crucial to deepen our understanding of toxic pollutants, toxicity patterns, regulatory mechanisms, and decontamination strategies, as preventing aflatoxin contamination needs adequate funding and collaboration.

12 February 2025 in International Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
BBBysani Suresh Babu
Bysani Suresh Babu
NBNalanda Revu Baby
Nalanda Revu Baby
SMSumanta Mondal
Sumanta Mondal
Objectives This study describes developing and validating a novel method using LC-MS/ MS to measure the concentration of Momelotinib in rat plasma.Materials and Methods The pharmacokinetic applicability of the process was assessed in rats using a Symmetry C18 column (250 mmx4.6 mm, 5 µm) at room temperature for separation. The mobile phase consisted of a mixture of acetonitrile and 0.1% formic acid (45:55) with a 1.0 mL/min flow rate and an injection volume of 10 µL. The Liquid Chromatography (LC) process was carried out over 5 min, with the mass spectrometer operating in positive ESI mode. The mass-to-charge ratio transitions for Momelotinib and Oclacitinib were determined as m/z 415.4285→160.4698 and 338.2142→266.9137, respectively.Results and Discussion The concentration range for Momelotinib was established at 7.50-60.00 ng/mL, with a correlation coefficient of 0.9999. The precision and accuracy for High-Quality Control (HQC), Medium-Quality Control (MQC), Low-Quality Control (LQC) and Lower Limit of Quantification (LLQC) were 97.52%, 98.97%, 95.46% and 92.55%, respectively. The recovery accuracy for Momelotinib was found to be 97.29%. In pharmacokinetic studies, Momelotinib exhibited an average AUC0-t of 156 ng-hr/mL and a Cmax of 27.2 ng/mL in rats.Conclusion In conclusion, this validated approach effectively demonstrates the determination of pharmacokinetic parameters following the oral administration of Momelotinib in Wistar rats.

3 November 2026 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
SMSourav Mandal
Sourav Mandal
KRKamalakanta Ray
Kamalakanta Ray
ICIndranil Chatterjee
Indranil Chatterjee
PMProjna Mridha
Projna Mridha
SSSoumitra Sahana
Soumitra Sahana
TSTapan Kumar Shaw
Tapan Kumar Shaw
Keratin is a fibrous structural protein that occurs in abundance in hair, wool, feathers, horns, and nails, and it is a valuable biopolymer with great biomedical applications. The poultry, textile, and leather industries produce millions of tons of keratin waste annually, resulting in significant environmental problems due to their negligible biodegradability as well as the lack of environmentally friendly disposal methods. Recent studies have moved towards valorizing keratin waste, where ongoing research in extraction, purification, and modification techniques has made its applications viable in wound healing, tissue engineering, drug delivery, cosmetics, and ecological remediation. In contrast to previous reviews, this article presents a critical evaluation of traditional, chemical, and industrial extraction methods, focusing on their efficiency, scalability, and sustainability. This study also emphasizes biomedical applications, addresses the challenges and bottlenecks like immunogenicity, reproducibility, and regulatory hurdles, and charts future research agendas for the development of keratin-based biomaterials within a circular bioeconomy scenario. Thus, this review closes the gap between keratin waste management and biomedical innovation and provides novel insights toward sustainable exploitation and next-generation therapeutic applications.